Literature DB >> 23140366

Aging, cellular senescence, and cancer.

Judith Campisi1.   

Abstract

For most species, aging promotes a host of degenerative pathologies that are characterized by debilitating losses of tissue or cellular function. However, especially among vertebrates, aging also promotes hyperplastic pathologies, the most deadly of which is cancer. In contrast to the loss of function that characterizes degenerating cells and tissues, malignant (cancerous) cells must acquire new (albeit aberrant) functions that allow them to develop into a lethal tumor. This review discusses the idea that, despite seemingly opposite characteristics, the degenerative and hyperplastic pathologies of aging are at least partly linked by a common biological phenomenon: a cellular stress response known as cellular senescence. The senescence response is widely recognized as a potent tumor suppressive mechanism. However, recent evidence strengthens the idea that it also drives both degenerative and hyperplastic pathologies, most likely by promoting chronic inflammation. Thus, the senescence response may be the result of antagonistically pleiotropic gene action.

Entities:  

Mesh:

Year:  2012        PMID: 23140366      PMCID: PMC4166529          DOI: 10.1146/annurev-physiol-030212-183653

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  146 in total

1.  Glucocorticoids suppress selected components of the senescence-associated secretory phenotype.

Authors:  Remi-Martin Laberge; Lili Zhou; Melissa R Sarantos; Francis Rodier; Adam Freund; Peter L J de Keizer; Su Liu; Marco Demaria; Yu-Sheng Cong; Pankaj Kapahi; Pierre-Yves Desprez; Robert E Hughes; Judith Campisi
Journal:  Aging Cell       Date:  2012-04-17       Impact factor: 9.304

2.  Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression.

Authors:  Ermira Pazolli; Elise Alspach; Agnieszka Milczarek; Julie Prior; David Piwnica-Worms; Sheila A Stewart
Journal:  Cancer Res       Date:  2012-03-15       Impact factor: 12.701

3.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

4.  Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.

Authors:  Tae-Won Kang; Tetyana Yevsa; Norman Woller; Lisa Hoenicke; Torsten Wuestefeld; Daniel Dauch; Anja Hohmeyer; Marcus Gereke; Ramona Rudalska; Anna Potapova; Marcus Iken; Mihael Vucur; Siegfried Weiss; Mathias Heikenwalder; Sadaf Khan; Jesus Gil; Dunja Bruder; Michael Manns; Peter Schirmacher; Frank Tacke; Michael Ott; Tom Luedde; Thomas Longerich; Stefan Kubicka; Lars Zender
Journal:  Nature       Date:  2011-11-09       Impact factor: 49.962

5.  Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells.

Authors:  Tatjana M Trost; Ekkehart U Lausch; Stephan A Fees; Steffen Schmitt; Thorsten Enklaar; Dirk Reutzel; Lili R Brixel; Peter Schmidtke; Marko Maringer; Ilka B Schiffer; Carolin K Heimerdinger; Jan G Hengstler; Gerhard Fritz; Ernst O Bockamp; Dirk Prawitt; Bernhard U Zabel; Christian Spangenberg
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

6.  p16INK4a modulates p53 in primary human mammary epithelial cells.

Authors:  Jianmin Zhang; Curtis R Pickering; Charles R Holst; Mona L Gauthier; Thea D Tlsty
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

7.  Real-time in vivo imaging of p16Ink4a reveals cross talk with p53.

Authors:  Kimi Yamakoshi; Akiko Takahashi; Fumiko Hirota; Rika Nakayama; Naozumi Ishimaru; Yoshiaki Kubo; David J Mann; Masako Ohmura; Atsushi Hirao; Hideyuki Saya; Seiji Arase; Yoshio Hayashi; Kazuki Nakao; Mitsuru Matsumoto; Naoko Ohtani; Eiji Hara
Journal:  J Cell Biol       Date:  2009-08-10       Impact factor: 10.539

Review 8.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

9.  Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells.

Authors:  D J Kurz; S Decary; Y Hong; J D Erusalimsky
Journal:  J Cell Sci       Date:  2000-10       Impact factor: 5.285

10.  Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence.

Authors:  Graeme Hewitt; Diana Jurk; Francisco D M Marques; Clara Correia-Melo; Timothy Hardy; Agata Gackowska; Rhys Anderson; Morgan Taschuk; Jelena Mann; João F Passos
Journal:  Nat Commun       Date:  2012-02-28       Impact factor: 14.919

View more
  935 in total

Review 1.  Senescent cells: an emerging target for diseases of ageing.

Authors:  Bennett G Childs; Martina Gluscevic; Darren J Baker; Remi-Martin Laberge; Dan Marquess; Jamie Dananberg; Jan M van Deursen
Journal:  Nat Rev Drug Discov       Date:  2017-07-21       Impact factor: 84.694

Review 2.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

Review 3.  DNA Damage, DNA Repair, Aging, and Neurodegeneration.

Authors:  Scott Maynard; Evandro Fei Fang; Morten Scheibye-Knudsen; Deborah L Croteau; Vilhelm A Bohr
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-18       Impact factor: 6.915

Review 4.  A regulatory loop connecting WNT signaling and telomere capping: possible therapeutic implications for dyskeratosis congenita.

Authors:  Rafael Jesus Fernandez; F Brad Johnson
Journal:  Ann N Y Acad Sci       Date:  2018-04       Impact factor: 5.691

5.  Inactivation of yeast Isw2 chromatin remodeling enzyme mimics longevity effect of calorie restriction via induction of genotoxic stress response.

Authors:  Weiwei Dang; George L Sutphin; Jean A Dorsey; Gabriel L Otte; Kajia Cao; Rocco M Perry; Jennifer J Wanat; Dimitra Saviolaki; Christopher J Murakami; Scott Tsuchiyama; Brett Robison; Brian D Gregory; Michiel Vermeulen; Ramin Shiekhattar; F Brad Johnson; Brian K Kennedy; Matt Kaeberlein; Shelley L Berger
Journal:  Cell Metab       Date:  2014-05-08       Impact factor: 27.287

Review 6.  Restoration of mitochondria function as a target for cancer therapy.

Authors:  Tariq A Bhat; Sandeep Kumar; Ajay K Chaudhary; Neelu Yadav; Dhyan Chandra
Journal:  Drug Discov Today       Date:  2015-03-09       Impact factor: 7.851

7.  Alternatives to sural nerve grafts in the upper extremity.

Authors:  Louis H Poppler; Kristen Davidge; Johnny C Y Lu; Jim Armstrong; Ida K Fox; Susan E Mackinnon
Journal:  Hand (N Y)       Date:  2015-03

Review 8.  Revisiting the hallmarks of cancer.

Authors:  Yousef Ahmed Fouad; Carmen Aanei
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

9.  Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment.

Authors:  Ok Hee Jeon; Chaekyu Kim; Remi-Martin Laberge; Marco Demaria; Sona Rathod; Alain P Vasserot; Jae Wook Chung; Do Hun Kim; Yan Poon; Nathaniel David; Darren J Baker; Jan M van Deursen; Judith Campisi; Jennifer H Elisseeff
Journal:  Nat Med       Date:  2017-04-24       Impact factor: 53.440

10.  Subcellular distribution and activity of mechanistic target of rapamycin in aged retinal pigment epithelium.

Authors:  Bo Yu; Pei Xu; Zhenyang Zhao; Jiyang Cai; Paul Sternberg; Yan Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-09       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.